Isofol Medical AB
Records under this name other than the patents Isofol Medical AB holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 7 patents it holds.
Showing 1 to 3 of 3 · Back to Isofol Medical AB
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,138,435 | Reduction of toxicity of multi-targeting antifolates Lapsed on the fee record Ended Sep 22, 2023 · USPTO record | Lapsed on the fee record | Ended Sep 22, 2023 | USPTO record |
| US 9,675,617 | Tetrahydrofolates in combination with EGFR-inhibitors Lapsed on the fee record Ended Jun 13, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 13, 2021 | USPTO record |
| US 9,585,888 | Reduction of toxicity of multi-targeting antifolates Lapsed on the fee record Ended Mar 7, 2021 · USPTO record | Lapsed on the fee record | Ended Mar 7, 2021 | USPTO record |